亿帆医药：调剂2.4亿元担保额度并为子公司提供最高2700万欧元担保

Core Viewpoint - The company has announced an adjustment of its guarantee quota, reallocating unused guarantees to its wholly-owned subsidiary, increasing the total guarantee amount for the subsidiary to 240 million yuan [1] Group 1: Guarantee Adjustments - The company will adjust the unused guarantee quota of 240 million yuan to its wholly-owned subsidiary, Neso Pharmaceutical, increasing the total guarantee amount to 240 million yuan [1] - The company plans to provide a joint liability guarantee of up to 27 million euros for financing applications made by Neso Pharmaceutical to two banks [1] - The subsidiary, NovoTek, will provide collateral guarantees with its 100% equity stake in Neso Pharmaceutical [1] Group 2: Financial Metrics - As of the announcement date, the cumulative external guarantee balance of the company and its controlling subsidiaries is 5.252 billion yuan, which accounts for 61.63% of the audited net assets for 2024 [1]